Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Bayer/Genzyme drug discovery collaboration

Dec. 24, 1997

Therapeutics discovery collaboration formed by Ontogeny and ArQule

Dec. 23, 1997

New prodrug approach claimed by Merck & Co.

Dec. 23, 1997

Cel-Sci and NCI to test L.E.A.P.S. in NCI animal models of cancer

Dec. 22, 1997

Antibody-based therapeutics alliance formed by CAT and Icos

Dec. 22, 1997

LifeCell's ThromboSol to enter clinical feasibility study

Dec. 17, 1997

Orally activated protein therapy reported

Dec. 16, 1997

Scherer-Sankyo Zydis formulation agreement

Dec. 16, 1997

ICAgen and Abbott join forces for ion channel research

Dec. 16, 1997

Emisphere and Novartis sign agreement for drug delivery research

Dec. 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...